Patient Support Services Contact Us
Building on our success with UDENYCA® (pegfilgrastim-cbqv), we are now expanding our mission to immuno-oncology with Junshi Biosciences’ novel
Toripalimab is an investigational new drug currently being evaluated by the FDA for commercial distribution in the United States.
Coherus BioSciences, Inc. is proud to team up with our UDENYCA® (pegfilgrastim-cbqv) biomanufacturing partner KBI Biopharma and their parent company JSR Life Sciences to donate $40,000 to the Boulder County Wildfire Fund to support the heroic first responders who helped save the community from the recent Marshall Fire.
Community Foundation Boulder County launched the Fund and will work closely with government and nonprofit partners to coordinate, align resources and fill gaps to support those impacted by the wildfire. KBI has two facilities in the areas most directly impacted, and many KBI employees from the Boulder site were personally affected, ranging from complete loss of their homes and smoke damage to evacuations and neighborhood disruption. The UDENYCA® supply chain was not disrupted.
To date, Community Foundation Boulder County has distributed more than $5 million in financial assistance to thousands of people whose homes have been destroyed or damaged or were evacuated.
Learn more about the Marshall Fire disaster recovery efforts